21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Treatment for Diseases Caused By RNA Viruses
#8102COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDS
#8103METHODS FOR ENHANCING SLEEP QUALITY
#8104IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES
#8105AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE
#8106METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION
#8107BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY IN THE PREVENTION AND/OR TREATMENT OF HYPERTRIGLYCERIDEMIA
#8108REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF
#8109COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY
#8110Nucleoside derivatives and methods of use thereof
#8111METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS
#8112INHIBITION OF SLC TRANSPORTER ACTIVITY OR EXPRESSION TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY
#8113COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING HBV
#8114COMPOSITIONS AND METHODS FOR ENHANCING WNT SIGNALING FOR TREATING CANCER
#8115COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME
#8116TREATMENT OF BRAIN CANCER
#8117PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A PROGRAMMED DEATH-LIGAND 1 (PD-L1) INHIBITOR AND METHODS OF USE THEREOF
#8118AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING FROM SEPSIS, SEPTIC SHOCK, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)
#8119SMALL MOLECULE THERAPEUTICS FOR THE TREATMENT OF VIRAL INFECTIONS
#8120LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF
#81214-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT
#8122METHOD OF TREATMENT OF SCHIZOPHRENIA
#8123METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE
#8124TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE
#8125METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF PANCREATIC CANCER
#8126P38 GAMMA INHIBITORS AND METHOD OF USE THEREOF
#8127PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS
#8128PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION
#8129COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY
#8130COMPOSITIONS FOR AND METHODS OF PRECISION CANCER TREATMENT
#8131STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN INJURY
#8132METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND
#8133METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS
#8134Methods for Reduction of Body Weight with Subcutaneous Formulations
#8135PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF
#8136Efficacy of a Gastro-Retentive Bile Acid Sequestrant Dosage Form
#8137COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION
#8138METHOD FOR REDUCING OFF-TARGET UPTAKE OR ACCUMULATION OF AGENTS
#8139Topical Aerosol Foams
#8140DIAGNOSIS AND TREATMENT OF CANCER
#8141DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF PIWI AND/OR NMD COMPLEX PROTEIN
#8142METHODS FOR TREATING BLADDER CANCER
#8143PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF
#8144Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
#8145ANTIBODIES THAT BIND TO LRP5 PROTEINS AND METHODS OF USE
#8146FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING
#8147METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION
#8148RCOM PROTEIN BASED CARBON MONOXIDE SCAVENGERS AND PREPARATIONS FOR THE TREATMENT OF CARBON MONOXIDE POISONING
#8149VARIANT ACTRIIB PROTEINS AND USES THEREOF
#8150Crystal Form of Macrocyclic Tyrosine Kinase Inhibitor and Preparation Method therefor
#8151Macrocyclic MCL-1 Inhibitors and Methods of Use
#8152NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY
#8153NEW TRIAZINOINDOLE COMPOUNDS
#8154Inhibitors of cyclin-dependent kinases
#8155RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#81568-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
#8157SUBSTITUTED PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF
#8158ANTIBACTERIAL COMPOUNDS
#8159INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT
#8160COCRYSTALS OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID
#8161Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
#8162Methods for making and using endoxifen
#8163Sodium thiosulfate-containing pharmaceutical compositions
#8164APPLICATION OF AAV44.9 VECTOR IN GENE THERAPY FOR THE INNER EAR
#8165CCR7 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER
#8166STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#8167COMPOSITIONS AND METHODS FOR STEM CELL TRANSPLANT CONDITIONING AND USES THEREOF
#8168Anti-TIGIT Antibodies
#8169METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#8170PREVENTION AND TREATMENT OF ORGAN INJURIES
#8171NOVEL ANTIBACTERIAL PEPTIDE OR PEPTIDE ANALOG AND USE THEREOF
#8172NOVEL FORMUATIONS
#8173SKIN SENSITIZER DELIVERY SYSTEM
#8174COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF A PERFUSION DISORDER
#8175METHOD TO IMPROVE CANCER VACCINES
#8176Chimeric antigen receptors targeting FLT3
#8177MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
#8178Enhancement of vaccine efficacy and antibiotic efficacy
#8179Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory Conditions
#8180TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#8181TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#8182INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#8183PROGESTOGEN FORMULATIONS AND USES THEREOF
#8184FORMULATIONS AND METHODS OF TREATING COVID-19 AND PREVENTING INFECTION WITH SARS-CoV-2
#8185PRMT5 INHIBITORS FOR OCULAR THERAPY
#8186COMPOSITIONS AND METHODS FOR TREATING LUNG INJURIES ASSOCIATED WITH VIRAL INFECTIONS
#8187Organic compounds
#8188Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use
#8189Diketopiperazine Microparticles with Defined Specific Surface Areas
#8190USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
#8191CRENOLANIB COMBINATION THERAPY
#8192COMPOUND FOR PREVENTING OR TREATING A VIRAL INFECTION
#8193Methods of Using C-Met Modulators
#8194USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS
#8195AGENT FOR PROTECTING AND/OR REGENERATING NEUROMUSCULAR JUNCTION
#8196DOSING REGIMENS FOR USE IN TREATING RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH VENETOCLAX
#8197TREATMENT OF CARM1-OVEREXPRESSING AND/OR ARID1A MUTANT CANCERS WITH IRE-1/XBP-1 INHIBITORS
#8198USE OF A PROTEASOME INHIBITOR FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS
#8199PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
#8200APICAL SODIUM-DEPENDENT TRANSPORTER INHIBITOR COMPOSITIONS
#8201Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
#8202ISOTOPICALLY ENRICHED ANALOGS OF 5,6-METHYLENEDIOXY-2-AMINOINDANE (MDAI)
#8203USE OF HYDROPEROXY ALCOHOLS AND THE DERIVATIVES THEREOF AS ANTIMICROBIAL AGENTS
#8204Prevention of rosacea inflammation
#8205Combination therapy to treat urea cycle disorders
#8206Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer
#8207PRO-LYCOPENE RICH COMPOSITION AND METHODS OF USING SAME
#8208COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY
#8209COMPOSITIONS IN SUPPORT OF HEALTH AND MENTAL ACCUITY
#8210Uses and Formulations of Cannabinoids
#8211COMPOSITION COMPRISING METHYLFOLATE
#8212TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS
#8213COMPOSITIONS AND METHODS FOR DETECTING GENE FUSIONS OF ESR1 AND CCDC170 FOR DETERMINING INCREASED RESISTANCE TO ENDOCRINE THERAPY AND FOR CANCER TREATMENT
#8214CHANNEL MODULATORS
#8215SYSTEMS AND METHODS FOR VIRAL GENOME TARGETING
#8216BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION
#8217METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#8218COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#8219ANTI-CD26 PROTEINS AND USES THEREOF
#8220Monoclonal Antibodies and Antigen Binding Fragments Thereof for Suppressing CD73 Immune Checkpoint and Uses Thereof
#8221METHODS OF TREATING CASTRATE-RESISTANT PROSTATE CANCER
#8222AGONISTIC TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES
#8223TOCILIZUMAB AND REMDESIVIR COMBINATION THERAPY FOR COVID-19 PNEUMONIA
#8224Antibodies Binding to ILT4
#8225METHODS AND COMPOSITIONS FOR MODULATING LIPID STORAGE IN ADIPOSE TISSUE
#8226ANTI-C5 ANTIBODIES AND USES THEREOF
#8227METHODS AND COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM
#8228HDM-2 TARGETING COMPOSITIONS CAUSE TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS
#8229COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
#8230RADIO-AND CHEMO-PROTECTIVE COMPOUNDS
#8231SALT AND CRYSTAL FORMS OF 4-AMINO-5-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZO[D]IMIDAZOL-2-YL)THIENO[2,3-B]PYRIDIN-6(7H)-ONE
#8232Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of Protein Arginine Methyl Transferase 5 (PRMT5)
#8233Compounds useful in HIV therapy
#8234CRYSTALLINE FORMS AND FORMULATIONS OF A VCP/p97 INHIBITOR
#8235Benzisoxazole Sulfonamide Derivatives
#8236KRAS G12D PROTEIN INHIBITORS
#8237AMIDE COMPOUNDS AND USES THEREOF
#8238CDK inhibitors
#8239NEW ANTI-MALARIAL AGENTS
#8240Deuterated compounds and uses thereof
#8241NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER
#8242COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#8243COMPOSITIONS AND METHODS FOR TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA AND ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL
#8244FATTY ACYL AND FATTY ETHER CONJUGATES OF REMDESIVIR AND ITS ACTIVE METABOLITES AS ANTIVIRALS
#8245PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
#8246METHODS OF TREATING HER2 POSITIVE CANCER WITH TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND AN OXALIPLATIN-BASED CHEMOTHERAPY
#8247FUSION PROTEINS AND METHODS OF USE THEREOF
#8248MULTICOMPONENT CHEMICAL COMPOSITION OF A PEPTIDE-BASED NEOANTIGEN VACCINE
#8249METHOD AND DRUG FOR TREATING ALZHEIMER DISEASE
#8250ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE
#8251IL-18 Binding Protein (IL-18BP) In Respiratory Diseases
#8252AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM
#8253COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA
#8254THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME
#8255CONTROLLED RELEASE HYALURONIC ACID COMPOSITIONS
#8256BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT
#8257COMPOSITION FOR THE PREVENTION AND TREATMENT OF FOLATE AND/OR VITAMIN B12 DEFICIENCY CONDITIONS, PARTICULARLY HYPERHOMOCYSTEINEMIA
#8258TARGETING LTBP3 FOR NONALCOHOLIC STEATOHEPATITIS (NASH)-INDUCED LIVER FIBROSIS
#8259Nucleoporins as drug targets for anti-proliferative therapeutics
#8260NRTIS, NRTI METABOLITES, AND NRTI ANALOGS FOR MACULAR DEGENERATION AND VIRAL INFECTIONS
#8261THERAPEUTICS FOR COVID-19
#8262Combinatorial therapy for use in inducing immunogenic cell death in cancer cells
#8263SKIN-CARE COMPOSITIONS AND USES THEREOF
#8264AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENT
#8265COMPOUNDS FOR USE IN THE REACTIVATION OF HIV IN LATENT HIV-INFECTED CELLS
#8266METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE
#8267Antibody drug conjugates comprising sting agonists
#8268SARS-COV-2 INHIBITORS
#8269INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE
#8270METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING
#8271PREVENTION AND TREATMENT OF EFFECTS OF AGING AND AGE-ASSOCIATED DISORDERS WITH KETONE SUPPLEMENTATION
#8272THIOL-CONTAINING COMPOUNDS FOR USE IN TREATING CORONAVIRUS
#8273Multidrug pain management package
#8274Use of an RXR agonist and taxanes in treating Her2+ cancers
#8275METHOD OF LYOPHILIZING LIPOSOMES
#8276DRUG DELIVERY SYSTEM WITH ENHANCED IMMUNE ACTIVE FUNCTION
#8277Vasoconstriction compositions and methods of use
#8278Antimicrobial Compositions and Related Methods of Use
#8279METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES
#8280STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#8281BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY FOR THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY DISEASES AND/OR INFLAMMATORY GASTROINTESTINAL DISEASES AND/OR CANCERS
#8282Hexokinase 2-specific inhibitors for use in acute central nervous system injury
#8283METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES
#8284METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST
#8285High affinity antibodies targeting tau phosphorylated at serine 413
#8286Prodrugs of L-BHDU and methods of treating viral infections
#8287METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES
#8288Compositions and methods for treating atopic dermatitis
#8289Compositions and methods for treating atopic dermatitis
#8290DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST
#8291PURINE DERIVATIVES AS SIK-3 INHIBITORS
#8292SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE
#8293QUINOLINE COMPOUNDS AND COMPOSITIONS FOR INHIBITING EZH2
#82941,2,4-oxadiazole derivatives as immunomodulators
#8295TREATMENTS OF INFLAMMATORY BOWEL DISEASE
#8296COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#8297Dosing Strategy that Mitigates Cytokine Release Syndrome for Therapeutic Antibodies
#8298A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#8299CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS
#8300TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS
#8301COMPOSITIONS AND METHODS COMPRISING STABLE REDUCED GLUTATHIONE
#8302Herbal Formulation for the Prevention and Management of COVID-19 by Regulating Immunomodulatory Properties
#8303REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF
#8304THERAPEUTIC AND DIAGNOSTIC USE OF MICROORGANISMS FOR COVID-19
#8305MICROBIAL CONSORTIA
#8306STEM CELL DRUG FOR TREATING DIABETES
#8307TREATMENT OF VIRAL INFECTIONS
#8308Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer
#8309TREATMENT OF EYE DISORDERS WITH URIDINE PHOSPHATE DERIVATIVES
#8310METHOD AND COMPOSITION FOR TREATING ALZHEIMERS
#8311Administration and dosage of diaminophenothiazines
#8312METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19
#8313ANTICOAGULANT COMPOUNDS AND METHODS AND DEVICES FOR THEIR PULMONARY USE
#8314Methods of Use for Single Molecule Compounds Providing Multi-Target Inhibition to Treat Covid 19
#8315COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4
#8316PARAXANTHINE-BASED COMPOSITIONS FOR ENHANCING MUSCLE FUNCTION, NITRIC OXIDE SIGNALING, AND/OR MUSCLE GLYCOGEN LEVELS
#8317USE FOR PROTECTING OR MITIGATING RADIATION DAMAGE, AND FOR PREVENTING OR TREATING PULMONARY FIBROSIS
#8318PYRIMIDINEDIONE COMPOUNDS
#8319N-SUBSTITUTED INDOLE DERIVATIVES
#8320NEW USES
#8321MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
#8322METHODS OF TREATING ACUTE LUNG INJURY USING EBSELEN
#8323Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
#8324DOPAMINERGIC MIMETICS
#8325Histone acetyltransferase activators and compositions and uses thereof
#8326NOCICEPTOR NEURONS CONTROL CANCER IMMUNOSURVEILLANCE
#8327METHOD FOR TREATING SYMPTOMS OF VIRAL INFECTIONS
#8328COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF
#8329BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS
#8330MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE
#8331Antimicrobial Compositions and Related Methods of Use
#8332HMGB1 RNA And Methods Therefor
#8333COMPOSITIONS AND METHODS FOR SILENCING SCN9A EXPRESSION
#8334METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS ASSOCIATED WITH INFECTIOUS DISEASE
#8335RIG-I Agonists and Methods of Using Same
#8336INHIBITION OF CYSTATINS FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS
#8337TRANSFERRIN RECEPTOR 1 TARGETING FOR CARCINOGENESIS PREVENTION
#8338METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R INHIBITOR
#8339ANTI-PD-L1 ANTIBODIES AND DIAGNOSTIC USES THEREOF
#8340CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS
#8341Anti-CD8 antibodies and uses thereof
#8342Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
#8343COMPOSITIONS AND METHOD OF MODULATING GROWTH FACTOR FUNCTION
#8344ANTI-C5A ANTIBODIES
#8345MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND USES THEREOF
#8346PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUCOSITIS INDUCED BY RADIOTHERAPY, CHEMOTHERAPY, OR COMBINATION THEREOF, COMPRISING GLP-2 DERIVATIVES OR LONG-ACTING CONJUGATE OF SAME
#8347NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS
#8348DAPHNANE DITERPENOID RESISTANT TO PROSTATE CANCER AND PREPARATION METHOD THEREOF
#8349RNA-BINDING PROTEIN MULTIMERIZATION INHIBITORS AND METHODS OF USE THEREOF
#8350ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS
#8351HTT modulators for treating Huntington's disease
#8352Compositions and methods for inhibiting kinases
#8353TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
#8354Modulators of Mas-related G-protein receptor X4 and related products and methods
#8355INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS AND USES THEREOF
#8356Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
#8357ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF
#8358ARYLAMIDES AND METHODS OF USE THEREOF
#8359ARYLAMIDES AND METHODS OF USE THEREOF
#8360Pantothenamide analogues
#8361PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING MICROBIAL INFECTIONS
#8362STIMULI RESPONSIVE BLOCK COPOLYMERS
#8363HSP70 Inhibitors and Methods of Using Same
#8364COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR THE TREATMENT OF OR REDUCING THE ONSET OF A HEALTH CONDITION
#8365NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND USES THEREOF
#8366GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-BASED INFECTION TREATMENTS
#8367MECHANICAL AND BIOCHEMICAL ACTIVATION AND CONTROL OF SKELETAL STEM CELLS FOR CARTILAGE REGENERATION
#8368USE OF CD83 IN COMBINATION THERAPIES
#8369COMPOSITIONS COMPRISING BACTERIAL STRAINS AND USE THEREOF FOR THE TREATMENT OF OCULAR DISEASES AND LESIONS
#8370Inhibition of enteric infection through the modulation of microbiota
#8371COMPOSITIONS COMPRISING BACTERIAL STRAINS
#8372METHODS FOR TREATING ACUTE RESPIRATORY INFLAMMATORY CONDITIONS AND CYTOKINE STORM SYNDROME
#8373METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY
#8374B CELL IMMUNOMODULATORY THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME
#8375TUMOR COMBINED IMMUNOTHERAPY
#8376COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
#8377METHODS AND REGIMENS FOR THE TREATMENT OF HEMATOLOGICAL CANCER
#8378PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN
#8379COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT
#8380BROMODOMAIN INHIBITORS
#8381SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE
#8382PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
#8383Treatment of Acute Respiratory Distress Syndrome and Other Disorders Involving Cytokine Storm Using BTK Inhibitors
#8384METHODS AND COMPOSITION FOR TREATMENT OF COVID-19 ILLNESS REQUIRING HOSPITALIZATION
#8385FOLATE COMPOSITIONS
#8386Method for treating RNA viral infections, including COVID-19 (SARS-CoV-2)
#8387Cancer therapy by degrading dual MEK signaling
#8388Deuterated analogs of elacridar
#8389METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS
#8390Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias
#8391PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND
#8392PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL HEPATITIS AND THE USE THEREOF
#8393Lasofoxifene treatment of breast cancer
#8394NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE
#8395Compositions comprising theanine, magnolia, and phellodendron
#8396HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE
#8397POLYMERIC NANOPARTICLES PROVIDING NUCLEIC ACIDS ENCODING TNF-a
#8398SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME
#8399METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM
#8400AEROSOL FORMULATION FOR COPD